Oculis Holding AG (OCS) Capital Expenditures (2022 - 2026)

Oculis Holding AG's (OCS) quarterly Capital Expenditures came in at -$8939.0 in Q1 2026, up 38.18% year-on-year from -$6469.2 in Q1 2025, and up 81.2% quarter-over-quarter from -$47544.5 in Q4 2025.

Oculis Holding AG (OCS) Capital Expenditures (2022 - 2026) Analysis & Trends

Oculis Holding AG's Capital Expenditures history runs 5 years deep, the most recent figure standing at -$8939.0 for Q1 2026.

  • On a quarterly basis, Capital Expenditures rose 38.18% year-over-year to -$8939.0 in Q1 2026; TTM through Mar 2026 was -$363691.2, a 38.33% decrease from a year earlier, with the FY2025 full-year figure at -$363044.7, down 38.86% from the prior year.
  • Capital Expenditures grew to -$8939.0 in Q1 2026 per OCS's latest filing, from -$47544.5 in the prior quarter.
  • Across five years, Capital Expenditures topped out at -$5636.8 in Q4 2023 and bottomed at -$1.6 million in Q4 2022.
  • The 5-year median for Capital Expenditures is -$65066.7 (2024), against an average of -$251973.4.
  • Across the five-year window, Capital Expenditures surged 99.65% in 2023 and plunged 1054.33% in 2024, its largest moves.
  • Year by year, Capital Expenditures stood at -$1.6 million in 2022, then jumped by 99.65% to -$5636.8 in 2023, then plunged by 1054.33% to -$65066.7 in 2024, then climbed by 26.93% to -$47544.5 in 2025, then surged by 81.2% to -$8939.0 in 2026.
  • Per Business Quant, the three latest OCS Capital Expenditures figures stand at -$8939.0 (Q1 2026), -$47544.5 (Q4 2025), and -$155013.6 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capital Expenditures (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -8,939.03
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 43.25 Mn
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 133.40 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 230.60 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 786,000.00
10 Alnylam Pharmaceuticals 35.71 Bn 32.70 Bn 959.66 Mn 21.83 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -8,939.03
Mar 31, 2026 -8,939.03
Dec 31, 2025 -47,544.45
Dec 31, 2025 -47,544.45
Sep 30, 2025 -155,013.58
Sep 30, 2025 -155,013.58
Jun 30, 2025 -152,194.17
Jun 30, 2025 -152,194.17
Mar 31, 2025 -14,459.26
Mar 31, 2025 -14,459.26
Dec 31, 2024 -65,066.75
Dec 31, 2024 -65,066.75
Sep 30, 2024 -177,747.92
Sep 30, 2024 -177,747.92
Dec 31, 2023 -5,636.77
Dec 31, 2023 -5,636.77
Sep 30, 2023 -21,510.90
Sep 30, 2023 -21,510.90
Dec 31, 2022 -1.62 Mn
Dec 31, 2022 -1.62 Mn